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ABSTRACT OF THE THESIS 
 
 
 
Mechanisms Underlying Diarrheal Disease in Enteric Salmonella Infections  
 
 
by 
 
 
Rashini Jayaratne   
 
 
Master of Science in Biology 
 
 
University of California, San Diego, 2017 
 
 
Professor Kim Barrett, Chair 
 
 
 
Non-typhoidal Salmonella is the most burdensome foodborne illness 
worldwide, yet despite its prevalence, the mechanism through which 
Salmonella causes diarrhea is not entirely known. Intestinal ion transporters 
play important roles in water absorption in the intestine, and can be a 
therapeutic target in Salmonella induced diarrhea, but there is not a complete 
understanding of which ion transporters Salmonella regulates. We have 
previously shown that infection with Salmonella causes decreased expression 
		 ix 
of the chloride/bicarbonate exchanger SLC26A3 (DRA; Down-Regulated in 
Adenoma) in the colonic tissues of mice. To better understand the mechanism  
of Salmonella infection in intestinal epithelial cells, we developed an enteroid 
model that mimics the crypt-villus axis of the intestines, and contains the four 
different cell subtypes found in the intestines (enterocytes, enteroendocrine, 
goblet, and Paneth cells). These enteroids were converted to enteroid-derived 
monolayers (EDM) to allow access to the apical membrane. With this model, 
we looked at changes in the Wnt/NOTCH signaling pathways responsible for 
controlling cell fate commitment in the intestines in addition to changes in DRA 
in both colonic and small intestinal EDM. We hypothesized that EDM would 
show similar decreases in DRA to those seen in vivo, in addition to alterations 
in Wnt/NOTCH signaling that may be linked to DRA down-regulation. We 
found that expression of both DRA and NICD (of the NOTCH signaling 
pathway) were decreased 6 h post infection. Our work shows the possibility of 
using EDM as a model to uncover mechanisms that can be targeted for 
therapeutic developments against diarrhea caused by Salmonella infection. 
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INTRODUCTION 
The Pathophysiology of Salmonella Infections 
Non-typhoidal Salmonella spp. (e.g., Salmonella enterica serovar 
typhimurium) are the most burdensome food-borne diarrheal pathogens; of the 
approximate 2.8 billion cases of diarrheal illness occurring worldwide annually, 
non-typhoidal Salmonella is estimated to be responsible for 3%, or 93.8 million 
of these cases (Majowicz et al., 2010). Further, of the 93.8 million cases of 
Salmonella induced gastroenteritis occurring worldwide annually, 
approximately 155,000 result in death (Majowicz et al., 2010).  
Salmonella is an enteric pathogen that is usually acquired through the 
consumption of a contaminated food or water source. Once ingested, 
Salmonella makes its way to the intestines, where it can enter the epithelium 
via two routes. Salmonella enters the epithelium either via M cells, which are 
specialized cells in the intestinal epithelium that allow immune cells to sample 
antigens in the lumen, or through intestinal epithelial cells (Broz et al., 2012). 
After Salmonella has crossed the intestinal barrier, resident immune cells 
located in the epithelium, such as macrophages, will phagocytose the 
pathogen. Once inside these macrophages, Salmonella will either be 
degraded by lysosomal enzymes, or will use special virulence factors to 
survive and replicate in the cytoplasm of the macrophages (Broz et al., 2012). 
Following invasion, Salmonella is thought to induce an inflammatory diarrhea 
caused by the influx of neutrophils and subsequent disruption of intestinal 
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barrier function by neutrophil activity. Although Salmonella does induce 
inflammation, it is likely that before the onset of inflammation, Salmonella, like 
most other diarrheal pathogens, causes watery-diarrhea by altering the 
expression and/or function of intestinal ion transporters present throughout the 
epithelium (Zhang et al., 2003). Previous work from our lab has shown that 
following Salmonella infection in mice, diarrhea develops before the onset of 
inflammation and is independent of neutrophil recruitment; infection in these 
mice does however eventually lead to inflammation and the influx of 
neutrophils. Here, we will focus on this initial phase of infection, before the 
onset of inflammation, where diarrhea is likely caused by alterations in 
transporter function.  
The Role of Ion Transporters in Diarrhea 
Ion transporters present throughout the intestines are responsible for 
the uptake of specific ions and nutrients, and function in the absorption of 
water (Supplementary Figure 1). The dysregulation of these transporters 
causes diarrhea (Field, 2003). The mechanism through which Salmonella 
causes changes in ion transport is not yet known. Elucidation of the 
mechanism(s) through which Salmonella causes diarrhea would aid in the 
development of novel therapeutics to combat Salmonella induced diarrhea.       
Diarrhea occurs either as a result of increased secretion of ions or 
decreased absorption of ions by intestinal transporters and ion channels 
(Field, 2003 and Barrett, 2016). An excess of ions present in the lumen of the 
intestines will cause an outflow of water from the intestines into the lumen. The 
		
3 
mechanism by which diarrhea is induced is known for some enteric 
pathogens. A commonly studied diarrheal pathogen, Vibrio cholerae, causes 
diarrhea by increasing the activity of CFTR (Cystic Fibrosis Transmembrane 
Conductance Regulator), a channel protein present in the intestines that is 
responsible for secreting chloride. Increased chloride secretion, caused by 
Vibrio cholerae, causes an outflow of water from the intestines resulting in 
diarrhea (Kimberg et al., 1971, Sharp and Hynie, 1971, and Broeck et al., 
2007). A more complete knowledge of similar downstream mechanism(s) 
behind Salmonella induced diarrhea is however still lacking.  
In Vivo Models Used to Study Salmonella Infection: A Novel Nramp1 
Wild-Type Model 
In order to further study Salmonella induced diarrhea an effective model 
needs to be established. Two models used in the study of Salmonella infection 
are bovine models and murine models. The bovine model, widely used in the 
past, accurately capitulated the pathophysiology of diarrhea seen in humans. 
Although this model proved extremely useful to understanding the progression 
of diarrhea in Salmonella infection, it was not as amenable to genetic 
manipulation for use in mechanistic studies of Salmonella infection (Santos et 
al., 2001). Murine models were therefore established to further investigate 
Salmonella infection. The initially established murine models however did not 
accurately recapitulate the pathophysiology of diarrhea seen during 
Salmonella infection in humans (Hapfelmeier and Hardt, 2005). Regular in-
bred laboratory mouse strains infected with Salmonella develop severe 
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disseminated infection, with bacterial invasion into the bloodstream leading to 
a quick death. This occurs because most inbred mouse strains have a mutant 
Nramp1 gene (Canonne‐Hergaux et al., 1999). Wild-type Nramp1 prevents 
Salmonella growth within the phagolysosome, preventing aberrant growth that 
can lead to sepsis (Canonne‐Hergaux et al., 1999). Recently however, our lab 
developed a model using Nramp1 wild-type mice, and found that when 
infected with Salmonella following kanamycin pretreatment to allow for 
sufficient colonization of Salmonella, these mice develop diarrhea similar to 
that seen in humans (Woo et al., 2008). When infected with Salmonella, these 
Nramp1 wild-type mice showed decreased expression of the transporters DRA 
and ENaC (epithelial sodium channel) along with a redistribution of CFTR to 
the cytosol. The expression of transporters NKCC1 (Na+-K+-2Cl- cotransporter) 
and NHE3 (Sodium-hydrogen exchanger 3) were unchanged (Marcheletta el 
al., 2013). Of these changes in ion transport, decreased expression of DRA 
provides a potential explanation for Salmonella induced diarrhea. DRA is a 
chloride bicarbonate exchanger responsible for absorbing chloride; therefore 
decreased DRA would cause decreased absorption of chloride. This would 
lead to excess chloride build-up in the lumen of the intestines, resulting in 
diarrhea. Changes in DRA expression following Salmonella infection, therefore 
warrant further investigation.  
Although experiments using Nramp1 wild-type mice to study Salmonella 
infection are effective, these experiments tend to be expensive and time 
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consuming. In addition, although mouse models are amenable to genetic 
manipulation, which is important in mechanistic studies, the manipulation of 
specific pathways in mice following infection is more complicated. Therefore, 
an alternate ex-vivo model that accurately mimics intestinal physiology and 
pathophysiology in the setting of diarrhea would be very useful to study 
Salmonella infection.  
In Vitro Models Used to Study Salmonella Infection: A Novel Enteroid 
Model 
Although in vitro models are used to study Salmonella infection, these 
models do not completely reflect intestinal physiology. A widely used cell line 
in the study of enteric infection is the Caco-2 cell line (heterogeneous human 
epithelial colorectal adenocarcinoma). When made into monolayers and 
allowed time to reach confluence, these cell lines do develop into a brush 
border, but only contain one cell type, enterocytes (Delie and Rubas, 1997).  
The intestinal epithelium is composed of four main cell types: Paneth cells, 
which secrete antimicrobial peptides, goblet cells, which secrete mucus, 
enteroendocrine cells, which secrete various hormones, and enterocytes, 
which mediate absorption of electrolytes and other solutes, such as nutrients 
(Cheng et al., 1974)(Supplementary Figure 2). These four cell types reside in 
different areas along the crypt-villus axis of the intestines, and stem cells 
located at the bottom of the crypts give rise to these four different cell types 
based on signals received from the Wnt and NOTCH signaling pathways (Pin 
et al., 2012)(Supplementary Figure 3). Until recently, it has been challenging 
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for in vitro models to accurately mimic this intestinal morphology. However, a 
new model involving the maintenance of intestinal stem cells in “organoids” 
that generate the differentiated lineages of epithelial cells listed above 
provides a useful solution to this problem.  
Organoids are unlike other in vitro models because they accurately 
model the crypt-villus axis of the intestines, and contain the four different cell 
types of the intestinal epithelium. These organoids are produced from 
intestinal stem cells plated in Matrigel (basement-membrane matrix) to create 
3D clusters of stem cells and their progeny that mimic the crypt-villus axis of 
the intestines (Sato et al., 2011). Organoids, also called “enteroids,” are 
maintained through serial passages in a proliferative state via the use of 
inhibitors that prevent differentiation. Enteroids can be differentiated into the 
four different cell types and made into enteroid-derived monolayers (EDM) to 
allow for an apical and basolateral polarization, which allows for apical 
infection with Salmonella (Miyoshi and Stappenbeck, 2013 and Foulke-Abel et 
al., 2016). Therefore organoids derived from mice present an efficient and 
effective model to study Salmonella infection. Moreover, recently Dr. Das’ 
group and others have been successful in isolating and culturing enteroids 
from healthy human patients and patients suffering from inflammatory bowel 
diseases, which opens up the future possibility of studying the mechanisms 
behind Salmonella infection using human intestinal organoids. Enteroids are 
also amenable to both overexpression and down-regulation of gene 
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expression via lentiviral transduction, which will aid in future mechanistic 
studies.  
Aims of The Research 
In order to better understand the mechanism(s) behind Salmonella 
infection we looked at changes in the Wnt/NOTCH signaling pathway in 
addition to changes in DRA using the enteroid model. The Wnt and NOTCH 
signaling pathways are relevant to the study of Salmonella infection because 
these two pathways control cell fate decisions in the intestines, and it is 
possible that Salmonella alters these pathways to cause aberrant proliferation 
of secretory over absorptive cell types to cause diarrhea. Liu et al. recently 
showed that the Salmonella effector AvrA increases levels of Wnt signaling. In 
addition it is possible that regulation of the Wnt and NOTCH signaling pathway 
is related to regulation of DRA. D’Angelo et al. showed that that the 
transcription factor HNF1α was responsible for regulating both Wnt/NOTCH 
signaling and DRA expression in the intestines (Liu et al., 2012 and D’Angelo 
et al., 2010).  
Although various transporters are involved in the control of fluid 
absorption in the intestines (Supplementary Figure 1), we will focus specifically 
on DRA. As previously mentioned, Marcheletta et al. showed that expression 
of DRA was decreased in mice following infection with Salmonella.  DRA is of 
interest in Salmonella infection because it has previously been implicated in 
other diarrheal diseases. Mutations in the DRA gene are responsible for 
causing diarrhea in CCLD (Congenital-Chloride Losing Diarrhea), a genetic 
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disorder characterized by severe high chloride content diarrhea (Höglund et 
al., 1996) Similarly, DRA knockout mice exhibit high chloride content diarrhea, 
aberrant growth of the intestinal mucosa, and crypt cell hyperplasia 
(Schweinfest et al., 2006).  
We hypothesize that EDM derived from both proximal colon and small 
intestine will show down-regulation of DRA in addition to alterations in Wnt and 
NOTCH signaling following infection with Salmonella. Previous studies have 
shown that Salmonella effectors are capable of stabilizing β-catenin of the Wnt 
signaling pathway (Liu et al., 2012). It is therefore possible that Salmonella 
infection can bias differentiation of the intestinal epithelium toward a secretory 
cell type, by activation of Wnt and downregulation of NOTCH signaling. To 
elucidate DRA expression and any alterations in the Wnt and NOTCH 
signaling pathway, we used EDM as a model for Salmonella infection and 
measured downstream changes in Wnt and NOTCH signaling, and DRA 
expression via RT-PCR, western blotting, and confocal microscopy.
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MATERIALS AND METHODS 
 
Isolation of Enteroids From Murine Intestine 
 
Female mice aged 5-6 weeks were rendered unconscious via CO2 and 
euthanized by cervical dislocation. The tissues of interest were dissected from 
these mice either from the distal end of the small intestine (ileum), a few 
inches from the cecum, or the proximal end of the colon, a few inches past the 
cecum, and placed in DMEM/F12 with HEPES (Sigma, St. Louis, MO) with 
added 10% FBS (Life Technologies, Gaithersburg, MD), 1% 
penicillin/streptomycin (100µg/ml, Sigma), 1% Glutamax (2mM, Life 
Technologies) (wash buffer). Tissues were opened longitudinally and scraped 
with forceps to remove villi and then subsequently washed in ice cold PBS 
(Life Technologies). Fat and connective tissue were removed from the tissue 
segments, and tissues were then minced thoroughly. 1ml of collagenase I 
solution (2mg/ml, Invitrogen, Carlsbad, CA) was added to the minced tissues 
and pipetted up and down; the mixture was incubated at 37°C for 10 minutes. 
The collagenase digestion step was repeated until individual crypts could be 
visualized under a microscope (digestion time was 40 minutes maximum). 
10ml of wash buffer was added to de-activate collagenase I, and the mixture 
was filtered using a 70-µm cell strainer (Corning, Salt Lake City, UT). The 
mixture was centrifuged at 100-200g and isolated crypts were suspended in 
laminin-rich Matrigel (Corning). The Matrigel mixture was plated on either 24-
well or 12-well plates (USA Scientific, Ocala, FL), inverted and allowed to
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 incubate at 37°C for 10 minutes as described in Miyoshi et al., before addition 
of 50% conditioned media (CM) containing Wnt3a, R-spondin, and Noggin to 
promote growth, along with inhibitors of Y27632 and SB431542 (inhibitors of 
ROCK and TGF-β, respectively)(Selleck Chemicals, Houston, TX) to prevent 
differentiation as described in Sato et al. (Miyoshi et al., 2013 and Sato et al., 
2009).  
Maintenance of Organoids/ Generation of Enteroid-Derived Monolayers  
Organoids derived from ileum and proximal colon were maintained as 
described above; suspended in laminin rich Matrigel in 50% CM with inhibitors 
of Y27632 and SB431542. These organoids were trypsinized and maintained 
through serial passages. In order to trypsinize organoids, 50% CM was 
removed and cells were scraped in cold 0.5 mM PBS-EDTA and spun down at 
200g. 0.025% Trypsin (Life Technologies) was added to the cell pellet based 
on pellet density, and incubated at 37°C for 3 min. An appropriate volume of 
wash buffer (twice the volume of Tryspin added) was used to deactivate 
Trypsin. The mixture was spun down at 200g, and pellet was resuspended in 
Matrigel. 50% CM with inhibitors of Y27632 and SB431542 was added to the 
suspension of cells after 10 minutes incubation of inverted Matrigel plate at 
37°C. Before infection, these enteroids were converted into EDM by 
trypsinizing as described above, and isolating single cells in 5% CM lacking 
SB431542 inhibitor. Cells were counted, and approximately 2 x 105 cells were 
added to permeable 6.5mm transwells (Corning) after coating the transwells 
with diluted Matrigel (1:30 in PBS) for 30min- 1 h. For western blots, 5 x 105- 1 
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x 106 cells were added to coated 12mm transwells (Corning). EDM were 
allowed to differentiate for two days in 5% CM media lacking SB431542 
inhibitor and Wnt3a before infection.  
Bacteria  
Salmonella enterica serovar typhimurium strain SL1344 was used for infection 
of EDM generated on transwells and RFP-tagged SL1344 was used for 
infection of EDM generated on 8-well chamber slides (Fischer Scientific, San 
Diego, CA) for confocal microscopy. For culture, bacteria were inoculated into 
Luria-Bertani (LB) broth and grown for 8 h under aerobic conditions in an 
orbital shaker at 150rpm with appropriate antibiotics as done previously (Das 
et al., 2011). The OD of the culture was taken using a spectrophotometer, and 
the appropriate amount of bacterial culture was collected and suspended in 
1ml of was buffer without penicillin/streptomycin in order to get 5 x 108 colony 
forming units (CFU). 
Infection 
Bacteria were added to EDM at a multiplicity of infection (moi) of 10:1. After 1 
h of invasion, cultures were washed and treated with gentamicin (50µg/ml, Life 
Technologies) for 90 minutes to kill remaining extracellular bacteria. 
Gentamicin was removed, and media was changed to 5%CM before collection 
of cell lysates at 6 or 24h. TER (transepithelial resistance) was measured at 
various time-points throughout infection and recorded as Ω*cm2. 
Real-time Polymerase Chain Reaction  
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Cell lysates were collected from infected EDM at the 6 h time point using Lysis 
Buffer (Quiagen, Valencia, CA) by following the manufacturer’s instructions. 
The lysate was placed onto an RNeasy column (Quiagen) and RNA isolated 
following the manufacturer’s instructions. RNA was made into cDNA using 
qScript cDNA supermix (Quantabio, Beverly, MA) following the manufacturer’s 
instructions and stored at -20°C. cDNA was then used to run polymerase 
chain reaction using a high capacity kit (Applied Biosystems, Carlsbad, CA) 
following the manufacture’s protocol. Primers used are listed in Supplementary 
Table 1. All reactions were performed using the Step-One Plus system 
(Applied Biosystems). Target genes were normalized to β-actin. The resulting 
Ct values were calculated using single delta Ct as 2(β-actin-Target) and expressed 
in units relative to control.  
Western Blot 
At a 6 h timepoint EDM were lysed in cold RIPA buffer (50 mM Tris-HCl, 150 
mM sodium chloride, 1mM EDTA, 0.25% sodium-deoxycholate, 1% NP40) 
with protease inhibitor and phosphatase inhibitor (Sigma) for 15 minutes on 
ice. After lysis, the samples were centrifuged and the supernatant collected. 
Equivalent amounts of protein for each sample were run on 10% 
polyacrylamide gels and then transferred onto a nitrocellulose membrane (Bio-
Rad, Hercules, CA). After transfer, the blot was blocked in either 5% non-fat 
milk (Lab Scientific Inc., Livingston, NJ) or 5% bovine serum albumin (Sigma) 
in phosphate-buffered saline containing 0.05% Tween-20 for 1 h at room 
temperature and incubated with rabbit anti-Down-Regulated in Adenoma (DRA 
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1:1000, Cell Signaling Technologies, Danvers, MA), rabbit anti- Notch 
intracellular domain (NICD, 1:1000, Cell Signaling Technologies) or mouse 
anti- β-actin (1:2000, Sigma) at 4°C overnight. Appropriate secondary 
antibodies, anti-rabbit IgG (1:2000, Cell Signaling) or anti-mouse IgG (1:2000, 
BD Biosciences, San Jose, CA) were added for 1.5 h at room temperature the 
following day, and the blot processed according to standard protocols with 
either SuperSignal West Pico Chemiluminescent Substrate or SuperSignal 
West Fempto Chemiluminescent Substrate (Thermo Fischer, San Diego, CA) 
and subsequent exposure to audioradiography film in a dark room (Genessee 
Scientific, San Diego, CA) for times ranging from 1 second- 5 minutes before 
developing. Densitometry was performed using ImageJ software (National 
Institutes of Health, Bethesda, MD).  
Confocal Microscopy  
EDM were generated on 8-well chamber slides. At a 6 h time point cells were 
fixed for 15 minutes in ice cold 4% paraformaldehyde pH 7.2-7.3 (Wako 
Chemicals, Richmond, VA) supplemented with 10% FBS. After fixation cells 
were permeabilized with 0.1% TritonX-100 in PBS and incubated with primary 
antibodies to DRA (1:80, Sigma) and ZO-1 (Zonula occludens-1, 1:50, Cell 
Signaling) overnight and secondary antibodies (Alexa Fluor 488 donkey anti-
rabbit 1:800 and DRAQ5 1:500) for 1.5 h before mounting with ProlongGold 
(Life Technologies). Imaging was performed using a Leica confocal 
microscope (Leica DMI4000B). 
Periodic-Acid Schiff Staining  
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PAS staining was used to stain for goblet cells. EDM were generated on 8-well 
chamber slides. At a 6h time point cells were fixed in 100% ethanol for 1 
minute and subsequently stained using Periodic acid-Schiff (PAS) kit (Sigma) 
following the manufacturer’s instructions.  
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RESULTS 
 
The generation of enteroid-derived monolayers from organoids  
In order to establish our enteroid model, proximal colon and ileum were 
harvested from mice and used to isolate intestinal crypts. Using cutting edge 
stem cell based techniques, Lgr5+ stem cells present in the crypts were 
maintained as spheroids (Figure 1A).  These spheroids were maintained 
undifferentiated through serial passages, until they reached an optimal 
density, and enough cells were available for making monolayers. Once the 
spheroids reached an ideal density, they were dissociated into single cells and 
differentiated into monolayers (enteroid-derived monolayers, EDM) on 
permeable transepithelial supports (Figure 1B). In order to test if the 
monolayers were differentiated, RT-PCR was used to test for Lgr5+ 
expression in both spheroids and monolayers (Figure 1C). EDM had lower 
Lgr5+ levels compared to spheroids, confirming that differentiation had 
occurred. Differentiated EDM were then used for infection.  
Salmonella infection of enteroid-derived monolayers disrupts tight 
junctions and epithelial barrier function  
 We first looked at how the epithelial barrier function of our monolayers 
was altered following Salmonella infection. EDM were infected with Salmonella 
and tight junction function was assesed via confocal microscopy for the tight 
junction protein ZO-1. Confocal microscopy showed that ZO-1 (green) was 
localized to the cell boundaries in uninfected EDM, but upon infection with
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 Salmonella, ZO-1, although still localized to the tight-junction, also appeared 
irregular and partially internalized (Figure 2A and B). In addition to 
redistribution of ZO-1, we wanted to see if overall barrier function was 
impaired following infection. In order to do this, epithelial barrier function of the 
monolayers was assessed by measuring the transepithelial resistance (TER) 
at various timepoints following infection. Uninfected EDM maintained stable  
values for TER, whereas infected EDM had TER reduced by half by 6 h post 
infection (Figure 2C). These results indicate that Salmonella infection of EDM, 
results in an overall decrease in intestinal barrier function.  
Salmonella infection of enteroid-derived monolayer results in decreased 
DRA expression  
 We then looked at whether or not Salmonella infection of EDM would 
cause a decrease in the chloride/bicarbonate exchanger down-regulated in 
adenoma (DRA) as previously seen in vivo in the proximal colon of mice. DRA 
expression was assessed via RT-PCR for transcript expression and western 
blots for protein expression in samples from both uninfected and infected EDM 
from both proximal colon and small intestine (Figure 3). DRA was found to be 
downregulated in infected EDM from both proximal colon and small intestine in 
both RT-PCR and western blot analyses. In addition to looking at the 
expression of DRA, we wanted to visualize the localization of DRA in EDM. 
DRA is an ion transporter, and in vivo it is present in the apical membranes of 
the cells of the villus, therefore, we expect to see DRA similarly localized 
around the cell boundary in EDM. Confocal microscopy using antibodies 
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against DRA showed that DRA (green) is localized around the outer border of 
cells in EDM generated from both colon and small intestine (Figure 4A). We 
also looked at the association of Salmonella with EDM (Figure 4B). Despite 
the ability to visualize DRA localization using confocal microscopy, we were 
unable to notice differences in the expression of DRA in uninfected versus 
infected EDM using this method of analysis. The inability to notice differences 
in expression may be due to a lack of polarization of EDM in 8-well chamber 
slides. Confocoal microscopy for DRA expression on polarized EDM 
generated on transwell inserts might provide more insight into DRA expression 
in EDM following Salmonella infection.  
Salmonella infection of enteroid-derived monolayers increases goblet 
cell proportion 
Salmonella effectors have been shown to stabilize the Wnt signaling 
pathway, one of the major pathways involved in determining cell fate 
commitment in the intestines (Liu et al., 2012). In addition, studies have also 
linked the regulation of the Wnt and NOTCH signaling pathway to the 
regulation of DRA expression (D’Angelo et al., 2010). We therefore wanted to 
investigate whether infection with Salmonella alteres cell fate commitment in 
the intestinal epithelium. Previous testing of the secretory-cell type markers, 
Muc2 and ATOH1 in EDM derived from small intestine showed increases in 
expression in these markers on a transcriptional level in infected versus 
uninfected EDM derived from small intestine. Muc2 is a marker for goblet cells 
while ATOH1 is a general secretory cell type marker. Therefore, we performed 
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Periodic-Acid Schiff (PAS) staining to try and visualize any changes in goblet 
cell number and mucus production in our EDM following Salmonella infection 
(Figure 5). Preliminary data from PAS staining of EDM derived from small 
intestine show an increase in the proportion of goblet cells in infected EDM 
when compared to uninfected EDM.  
Salmonella infection of enteroid-derived monolayers decreases NCID of 
the NOTCH signaling pathway  
 The increased proportion of goblet cells following infection of EDM with 
Salmonella suggested that there may be alterations in the Wnt and NOTCH 
signaling pathway. The previously observed increases in ATOH1 and Muc2 
taken with the increased proportion of goblet cells following infection points to 
a potential bias toward secretory cell fate commitment following Salmonella 
infection. To further investigate any changes in Wnt and NOTCH signaling, we 
looked at NICD (Notch-intracellular domain) expression following infection of 
EDM with Salmonella. NICD is a downstream signaling molecule involved in 
NOTCH signaling. We found that NICD was decreased following infection of 
both colonic and small intestinal EDM (Figure 6), offering a potential 
explaination for both the decreases in DRA and increases in goblet cells seen.  
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Figure 1: Differentiation of enteroids into EDM. Enteroids at day 2 after isolation from 
murine proximal colon (A). EDM derived from enteroids from murine proximal colon (B). 
Representative image of EDM generated on transwell inserts, infection with Salmonella occurs 
at the apical side of the monolayer (C). Lgr5, a stem cell marker, is decreased upon 
differentiation of enteroids into EDM (D). Data are from 2 independent experiments with a total 
n=2 for spheroid and n=6 for monolayer (P<0.05, Student’s T-Test).  
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Figure 2: Intestinal barrier function is impaired following Salmonella infection. Small 
intestinal EDM were infected with Salmonella strain SL1344, and treated with gentamicin after 
one hour to kill remaining extracellular bacteria, maintained 6h samples were fixed and 
stained for confocal microscopy for the tight junction protein ZO-1 (green). Monolayers show 
disruption of tight junctions in Salmonella infected (B) verses uninfected samples (A). Data is 
from 1 experiment with n=4 for both uninfected and infected EDM. Transepithelial resistance 
(TER) measurements show a 50% reduction in barrier function in infected samples from both 
small intestinal and colonic EDM following 6h of infection (C). Data are from 4 independent 
experiments with a total n=8 infected for small intestinal EDM (P<0.05, Student’s T-Test) and 
data are from 4 independent experiments with a total n=12 infected for colonic EDM (P<0.05, 
Student’s T-Test).  
 
A.  B. 
C. 
DRAQ5 
ZO-1 
DRAQ5 
ZO-1 
		
21 
 
 
 
	
 
                  
 
 
Figure 3: DRA is down regulated in both colonic and small intestinal EDM following 
Salmonella infection. EDM derived from mouse colon or small intestine were infected with 
Salmonella strain SL1344 and treated with gentamicin after one hour to kill remaining 
extracellular bacteria. Samples were lysed and collected at a 6 h time-point. Lysates were 
subsequently analyzed for DRA mRNA levels via RT-PCR (A). All uninfected samples were 
normalized to a value of 1. Data are from 5 independent experiments with a total n=9 infected 
for proximal colon. Data are from 7 independent experiments. n=12 infected for ileum 
(*P<0.05, Student’s T-test). The cell lysates from uninfected and infected, colonic and small 
intestinal EDM, after 6 h and 24 h of infection were loaded on SDS-PAGE and immunoblotted 
with DRA antibody (B). Equal loading was checked by probing the blot for the loading control 
β-actin. The blot is representative of three independent experiments for 6 h, only one 
experiment contained a 24 h time point; densitometry combining experiments is shown below 
the blot. Data is significant for the 6 h time point in both colonic and small intestinal EDM 
(P<0.05, Student’s T-Test).   
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Figure 4: Immunofluorescence staining for DRA shows localization of DRA in EDM. 
Uninfected EDM from both colon and small intestine were fixed and stained after 6 h for DRA 
(green)(A). DRA is localized around the boundary of the cells. EDM were infected with 
Salmonella strain SL1344 tagged with RFP, and treated with gentamicin after one hour to kill 
remaining extracellular bacteria, maintained 6 h samples were fixed and stained for confocal 
microscopy for DRA (green)(B). Salmonella are associating with EDM at the boundaries of the 
cells, some Salmonella appear to be internalized. 									
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Figure 5: Salmonella biases differentiation of the epithelium toward secretory lineages. 
EDM, derived from mouse small intestine were infected with Salmonella strain SL1344 treated 
and treated with gentamicin after one hour to kill remaining extracellular bacteria. Samples 
were lysed and collected at a 6 h time-point. Lysates were subsequently analyzed for ATOH1 
(A) and Muc2 (B) mRNA levels via RT-PCR. All uninfected samples were normalized to a 
value of 1. Data is from 2 independent experiments. EDM derived from mouse small intestine 
were infected with Salmonella strain SL1344 and treated with gentamicin after one hour to kill 
remaining extracellular bacteria. Samples were fixed and stained at 6 h using Sigma kit 395B-
1KT for goblet cells. A representative goblet cell is indicated with a white arrow in the first 
panel of (C). Data is representative of 2 independent experiments. 		
C. Uninfected Infected  
A.  B.  
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Figure 6: NICD is decreased following infection with Salmonella in both colonic and 
small intestinal EDM. EDM, derived from mouse proximal colon and ileum were infected with 
Salmonella strain SL1344, treated with gentamicin after one hour to kill remaining extracellular 
bacteria. The cell lysates from uninfected and infected, colonic and small intestinal EDM, after 
6 h of infection were loaded on SDS-PAGE and immunoblotted with NCID antibody. Equal 
loading was checked by probing the blot for the loading control Tubulin. Densitometry is 
shown below the blot. Data is from 1 independent experiment.  															
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DISCUSSION 
 
Previous studies from our lab have shown that DRA is down regulated 
in the proximal colon of mice prior to increased levels of inflammation 
(Marcheletta et al., 2013). Here, we focus on DRA expression in EDM derived 
from both the proximal colon and small intestine of mice. We hypothesized 
that EDM generated from both colon and small intestinal would show similar 
decreases in DRA as seen in vivo accompanied by alterations in the 
Wnt/NOTCH signaling pathways. In this study, we have found that DRA was 
down regulated in EDM derived from both proximal colon and ileum following 
infection with Salmonella similar to the results seen in vivo in the proximal 
colon of mice. Decreased expression of DRA following Salmonella infection 
offers a potential mechanism for Salmonella-induced diarrhea. Excess chloride 
ions in the lumen of the intestines as a result of decreased DRA expression 
contribute to water loss in the intestinal epithelium. In addition to quantifying 
DRA expression, we also used confocal microscopy to visualize DRA 
localization in EDM. In vivo DRA is localized at the apical side of the 
epithelium in cells of the villus. Our data show that similarly, in EDM, DRA is 
localized around the border of the cells.  
Confocal microscopy was also used to assess tight junction function 
following infection. In infected EDM, the tight junction protein ZO-1 appeared 
irregularly distributed at the tight junctional boundary between cells. ZO-1 was 
also slightly internalized in infected versus uninfected samples. Overall barrier 
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function assessed by TER measurements taken at time-points post-infection 
showed that infected EDM had significantly reduced barrier function by 1 h, 
consistent with the decreased ZO-1 seen via confocal microscopy. Decreased 
barrier function following infection of EDM could be attributed to the invasion of 
Salmonella into the epithelium. In vivo, Salmonella enter the intestinal 
epithelium either via M cells or invasion of epithelial cells through the use of 
T3SS-1 (type-three secretion system) effectors (Broz et al., 2012). A drawback 
to EDM as a model is that they lack M cells, in addition to immune cells usually 
present in the epithelium. Therefore in the EDM model, Salmonella most likely 
enter the cells solely via the use of T3SS-1 to manipulate cellular actin. This 
method of entry would account for altered ZO-1 localization, and impaired 
barrier function. Decreased barrier function leads to leaky tight junctions, 
which contribute to luminal fluid accumulation. During Salmonella infection in 
vivo inflammation occurs at a later stage after the onset of diarrhea, increased 
levels cytokines during this stage causes the recruitment of neutrophils, which 
in their efforts to contain infection cause damage to the tight junctional 
boundary (Broz et al., 2012). Because EDM lacks neutrophils, tight junctional 
deregulation most likely occurs as a result of invasion of Salmonella.  
In addition to changes in DRA expression, we looked at alterations in 
the Wnt and NOTCH signaling pathways following infection. The Wnt and 
NOTCH signaling pathways are responsible for controlling cell-fate 
commitment in the intestines, and it is likely that infection with Salmonella 
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alters these pathways. The alteration in these pathways may be linked with the 
down- regulation seen in DRA. Previous analysis of the secretory cell type 
marker ATOH1 and goblet cell specific marker Muc2 showed increased 
expression following Salmonella infection of small intestinal EDM. PAS 
staining of EDM similarly shows what appears to be an increased proportion of 
goblet cells. We next looked at whether or not increased goblet cell proportion 
was accompanied by changes in the Wnt and NOTCH signaling pathways. 
Expression of NICD, the downstream NOTCH signaling molecule, was 
decreased following infection of both colonic and small intestinal EDM. This is 
consistent with the observation that inhibition of NOTCH signaling leads to 
goblet cell hyperplasia (van Es et al., 2005). The interplay between the Wnt 
and NOTCH signaling pathway in the intestines is however complex. 
Increases in NOTCH signaling have been shown to result in no changes in 
certain components in the Wnt signaling pathway (van Es et al., 2005). In 
addition, AvrA, a Salmonella effector has been shown to cause up regulation 
of the Wnt signaling pathway, and other studies have shown that β-catenin 
can bind and activate Jagged1, a NOTCH ligand, leading to the activation of 
NOTCH signaling (Liu et al., 2012 and Rodilla et al., 2009). Preliminary data 
investigating the expression of both β-catenin and phospho- β-catenin 
following Salmonella infection in EDM show no significant changes to this 
pathway in uninfected versus infected EDM. In regards to Wnt and NOTCH 
activation in our EDM model, further investigation into the expression of the 
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Wnt signaling pathway will help to elucidate the interplay between these two 
pathways during Salmonella infection. 
The decreased NCID in EDM following infection could account for DRA 
down-regulation. Loss of NCID results in an inability of the intestinal epithelium 
to differentiate into absorptive cell types, and this could indirectly cause 
decreased transporter expression. It is also likely that loss of absorptive cell 
types is accompanied by decreases in DRA directly caused by Salmonella 
effectors. These two events could occur simultaneously, therefore further 
investigation is needed to determine whether decreased absorptive lineages is 
the only factor accounting for DRA down-regulation. In order to do this, γ-
secretase inhibitors could be used to block NOTCH signaling, and 
subsequently any downstream changes in DRA expression can be measured. 
The extent of DRA down-regulation as a result of γ-secretase inhibitors can be 
compared to the extent of DRA down regulation seen in Salmonella infection 
to determine if γ-secretase inhibition is the only mechanism contributing to 
DRA down regulation following Salmonella infection. If specific Salmonella 
effectors are contributing to DRA down-regulation, effector mutants could be 
used to test the role of individual effectors in causing DRA down-regulation.  
Another potential connection between the decreases seen in DRA, and 
increases in goblet cell number accompanied by decreased NOTCH signaling 
are the transcription factors Hepatocyte nuclear factor 1α and β. D’Angelo et al 
showed that mice deficient in HNF1α and β display increases in goblet cells 
along with decreases in DRA. Mice deficient in HNF1α and β also showed 
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decreases in both the NOTCH and Wnt signaling pathways (D’Angelo et al., 
2010). Preliminary data investigating the expression of HNF1α following 
infection of both colonic and small intestinal EDM however show no 
differences between uninfected and infected conditions. Although further 
investigation is needed, this suggests that there may be another mechanism 
at play that connects the decreases in DRA with increased goblet cell number 
and decreased NICD.  
In regards to potential therapeutics for Salmonella induced diarrhea, if 
DRA is the major cause of Salmonella induced diarrhea, then up-regulation of 
DRA should abrogate diarrhea. In future experiments, we plan to overexpress 
DRA in mice to determine whether or not this overexpression can reverse 
Salmonella induced diarrhea. If in fact overexpression of DRA can treat 
Salmonella induced diarrhea, compounds such as all-trans retinoic acid, which 
have been shown to increase DRA expression, could be used as a new form 
of therapeutic (Priyamvada et al., 2015).  
In conclusion, following Salmonella infection EDM show decreased 
intestinal barrier function, accompanied by decreases in the 
chloride/bicarbonate exchanger DRA, increased goblet cells, and decreased 
NOTCH signaling. Although the model is limited by the lack of immune cells, 
EDM provide a useful tool for further studying the mechanisms of Salmonella 
infection on the intestinal epithelium.  
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Supplementary Figure 1: Ion transporters present throughout the intestines aid in the 
absorption of ions and nutrients. The three sections of the small intestine are shown: 
duodenum, jejunum, and ileum. The large intestine is shown as the colon. Ion transporters are 
present at both the apical (DRA, CLCA, NHE2/3, SGLT1, and CFTR) and basolateral surfaces 
(NHE1 and NKCC1). The ions absorbed and/or secreted by each transporters are depicted via 
arrows either leading out of or into the intestinal epithelium.  
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Supplementary Figure 2: The organization of the crypt-villus axis. Lgr5+ stem cells 
present in at the base of the crypts give rise to the four main cell-types present in the 
intestines. Cell fate commitment is based upon signals received from the Wnt and NOTCH 
signaling pathways. 
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Supplementary Figure 3:  The Wnt and NOTCH signaling pathways control cell fate 
commitment in the intestines. In the NOTCH pathway binding of NOTCH ligands cause 
extracellular and intracellular cleavage of the NOTCH receptor. The intracellular fragment 
(NCID, Notch Intracellular Domain) translocates into the nucleus, where it causes the 
expression of a transcription factor, Hes1, which subsequently inhibits AtOH1 of the Wnt 
signaling pathway. Activation of NOTCH signaling gives rise to absorptive progenitors. ITCH 
and NUMB are negative regulators of the NCID causing its ubiquitin-mediated degradation. In 
the Wnt pathway, activation of the Wnt receptor stabilizes β-catenin, preventing its 
ubiquitination and subsequent degradation by the GSK/Axin complex. β-catenin is then 
translocated into the nucleus where is deactivates transcriptional repressors TCF and LEF, 
allowing the genes for ATOH1 to be transcribed. Activation of ATOH1 leads to downstream 
differentiation of the stem cells into secretory cell types.   
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Supplementary Table 1: Sequence of Primers Used for Expression Analysis (RT-PCR) 
 
DRA Forward: AGG GAA TGC TGA TGC AGT TTG CTG 
DRA Reverse: AGT TGA AAT GCT ACA CTT GCC GCC 
ATOH1 Forward: CCG TCA AAG TAC GGG AAC AG 
ATOH1 Reverse: GAG TAA CCC CCA GAG GAA GC 
Muc2 Forward: GAA GCC AGA TCC CGA AAC CA 
Muc2 Reverse:  GAA TCG GTA GAC ATC GCC GT 
β-actin Forward: GAC GGC CAG GTC ATC ACT AT 
β-actin Reverse:  ACA TCT GCT GGA AGG TGG AC 
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